Denali Therapeutics Ownership & Insider Activity

Denali Therapeutics (DNLI) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 2.0% of shares outstanding. Institutional investors hold 72.5%. Over the past 90 days, insiders made 4 sales worth $435K.

Shares Outstanding

159.847M

Shares Float

151.521M

Insider Shares Owned

3.233M

Insider % Owned

2.0%

Institutional Shares Held

115.821M

Institutional % Held

72.5%

Ownership Breakdown

Net Insider Activity by Month

Purchases (90d)

Sales (90d)

$435K total

Net Activity

Net Selling

Net Value (90d)

-$435K

Denali Therapeutics Insider Transactions (Last 6 Months)

Date	Insider	Title	Type	Shares	Price	Value
Sep 4, 2026	Scott Peter Chin	CHIEF MEDICAL OFFICER	SELL	1.654K	$22.29	$37K
Sep 2, 2026	Nancy Thornberry	DIRECTOR	SELL	11.439K	$22.90	$262K
Sep 1, 2026	Alexander Schuth	COFO AND SECRETARY	SELL	2.768K	$23.44	$65K
Aug 11, 2026	Alexander Schuth	COFO AND SECRETARY	SELL	2.857K	$25.07	$72K